| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |